| HS编码 | 商品名称 | 退税率 | 计量单位 | 海关监管 | 申报要素·检疫 | 编码对比 |
| 30044900.32 (增) | 丁丙诺啡和纳洛酮复方口服液体制剂
[Buprenorphine and naloxone combined oral liquid preparation] |
13% | 千克/ | I | 查看详情 | -- |
| 30012000.10 | 其他濒危野生动物腺体、器官
[Extracts of glands or other organs or of their secretions of endangered wild animals] |
0% | 千克/ | AQFEB | 查看详情 | 对比-30044900.32 |
| 30012000.21 | 含人类遗传资源的人类腺体、器官及其分泌物的提取物
[Human glands, organs and their secretion extracts containing human genetic resources] |
13% | 千克/ | ABV | 查看详情 | 对比-30012000.10 |
| 30012000.29 | 其他人类的腺体、器官及其分泌物的提取物
[Other human glands, organs and secretions extracts] |
13% | 千克/ | ABV | 查看详情 | 对比-30012000.21 |
| 30012000.90 | 其他腺体、器官及其分泌物提取物
[Other extracts of glands or other organs or of their secretions] |
13% | 千克/ | AB | 查看详情 | 对比-30012000.29 |
| 30019010.00 | 肝素及其盐
[Heparin and its salts] |
13% | 千克/ | Q | 查看详情 | 对比-30012000.90 |
| 30019090.11 | 濒危蛇毒制品
[Endangered snake venom (for therapeutic or prophylactic use)] |
0% | 千克/ | AQFEB | 查看详情 | 对比-30019010.00 |
| 30019090.19 | 非濒危蛇毒制品
[Non-endangered snake venom (for therapeutic or prophy-lacticuse )] |
13% | 千克/ | AQB | 查看详情 | 对比-30019090.11 |
| 30019090.20 | 含有人类遗传资源的人体制品
[Human body products containing human genetic resources] |
13% | 千克/ | ABQV | 查看详情 | 对比-30019090.19 |
| 30019090.91 | 其他濒危动物制品
[Other substances of endangered animal, prepared for therapeutic or prophylactic uses] |
0% | 千克/ | ABFEQ | 查看详情 | 对比-30019090.20 |
| 30019090.92 | 人类腺体、器官、组织
[Human glands, organs, tissues] |
13% | 千克/ | AB | 查看详情 | 对比-30019090.91 |
| 30019090.99 | 其他未列名的人体或动物制品
[Other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included] |
9%,13% | 千克/ | ABQ | 查看详情 | 对比-30019090.92 |
| 30021200.23 | 含有人类遗传资源的抗血清及其他血份
[Antiserum and other blood containing human genetic resources] |
13% | 千克/ | ABV | 查看详情 | 对比-30019090.99 |
| 30021200.30 | 兽用血清制品
[Veterinary serum products] |
13% | 千克/ | ABR | 查看详情 | 对比-30021200.23 |
| 30021200.93 | 罕见病药品制剂
[Rare disease drug preparation(Including the first and second batch of related products on the rare disease drug list)] |
13% | 千克/ | AB | 查看详情 | 对比-30021200.30 |
| 30021200.94 | 其他含濒危动物成分的抗血清及血份
[Other antisera and other blood fractions of endangered ani-mals] |
0% | 千克/ | ABEF | 查看详情 | 对比-30021200.93 |
| 30021200.99 | 其他抗血清及其他血份
[Other anti-serum and other blood types due to the resolution of anti-cancer drugs] |
13% | 千克/ | AB | 查看详情 | 对比-30021200.94 |
| 30021300.10 | 非混合的《兴奋剂目录》所列蛋白同化制剂和肽类激素免疫制品，未配定剂量或制成零售包装
[Non mixed protein assimilates and peptide hormone immune products listed in the "Catalogue of Doping Agents", without dosage or made into retail packaging] |
13% | 千克/ | ABL | 查看详情 | 对比-30021200.99 |
| 30021300.90 | 其他非混合的免疫制品，未配定剂量或制成零售包装
[Other non mixed immune products, not formulated in dosage or made into retail packaging] |
13% | 千克/ | AB | 查看详情 | 对比-30021300.10 |
| 30021400.00 | 混合的免疫制品，未配定剂量或制成零售包装
[Immunological products，mixed，not put up in measured doses or in forms or packings for retail sale] |
13% | 千克/ | AB | 查看详情 | 对比-30021300.90 |